What question did this study set out to answer?

To quantify the burden of chronic hepatitis B and project trends through 2030 in the Asia-Pacific region.

June 28, 2026Journal of Clinical and Translational Hepatology0 citationsOpen Access

Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study

ZLZhengzhao LuCapital Medical University DXDong Xu WJWei Ji

Key Points

To quantify the burden of chronic hepatitis B and project trends through 2030 in the Asia-Pacific region.
Utilized the Global Burden of Disease (GBD) 2023 framework to analyze data.
Focused on the Asia-Pacific region's hepatitis B statistics and related health outcomes.
Identified the Asia-Pacific region as having the largest share of global chronic hepatitis B cases.
Projected trends suggest challenges in meeting WHO 2030 elimination goals due to existing gaps in healthcare.

Abstract

The Asia-Pacific region accounts for a larger share of the hepatitis B burden than any other regions of the world, presenting a challenge to meeting the World Health Organization (WHO) 2030 elimination targets. In this study, we aimed to quantify the burden of chronic hepatitis B (CHB) and project its trends through 2030 using the GBD 2023 framework, thereby identifying gaps and priorities for the Asia-Pacific region to achieve WHO 2030 targets.

Ask AI

Helpful

Bookmark

View Full Paper